David Y. Graham, Saleh A. Naser, Thomas Borody, Zbigniew Hebzda, Harry Sarles, Scott Levenson, . . . Ira N. Kalfus. (2024). Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease. MDPI AG.
Chicago Style (17th ed.) CitationDavid Y. Graham, et al. Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease. MDPI AG, 2024.
MLA (9th ed.) CitationDavid Y. Graham, et al. Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.